Girish Mahajan (Editor)

Mitiglinide

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Trade names  Glufast
ATC code  A10BX08 (WHO)
PubChem CID  121891
Routes of administration  By mouth (tablets)
CAS Number  145375-43-5
Molar mass  315.41 g/mol
Mitiglinide
AHFS/Drugs.com  International Drug Names

Mitiglinide (INN, trade name Glufast) is a drug for the treatment of type 2 diabetes.

Contents

Mitiglinide belongs to the meglitinide (glinide) class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda. The North America rights to mitiglinide are held by Elixir Pharmaceuticals. Mitiglinide has not yet gained FDA approval.

Pharmacology

Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive potassium KATP channels in pancreatic β cells.

Dosage

Mitiglinide is delivered in tablet form.

References

Mitiglinide Wikipedia


Similar Topics
12 Years a Slave (film)
Konstantin Panov
Earnest Collins
Topics
 
B
i
Link
H2
L